{"product_id":"liposomal-vitamin-k2-mk-7-b2b-ingredient","title":"Liposomal Vitamin K2 MK-7 - B2B Ingredient","description":"\u003cp\u003e\u003cstrong\u003eLiposomal vitamin K2 MK-7 concept for low-dose distribution and dispersion.\u003c\/strong\u003e\u003c\/p\u003e\u003cp\u003eSingle-ingredient phospholipid-delivery vitamin K2 MK-7 concept designed for low-dose uniformity, dispersion, and formulation handling.\u003c\/p\u003e\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eModel Number:\u003c\/strong\u003e LIP-07\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eRelease Profile:\u003c\/strong\u003e Immediate\/non-modified release\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eComposition:\u003c\/strong\u003e Vitamin K2 MK-7 in a phospholipid delivery system (composition TBD)\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eUnit of Measure:\u003c\/strong\u003e kg\u003c\/li\u003e\n\u003c\/ul\u003e\u003cp\u003e\u003cem\u003eTechnical \u0026amp; regulatory notes: Secondary product added to the initial commercial range by NexaGens. Confirm potency, cis\/trans profile where applicable, low-dose uniformity, light\/oxidative stability, and phospholipid association. Immediate\/non-modified-release scope. Commercial release requires active identity and assay, phospholipid composition and active-to-phospholipid ratio, particle size and PDI, free versus associated active, morphology, stability, and a product-specific EU novel-food\/engineered-nanomaterial assessment. Source: NexaGens_Liposomal_Ingredient_Portfolio(2).docx.\u003c\/em\u003e\u003c\/p\u003e","brand":"NexaGens","offers":[{"title":"Default Title","offer_id":58506032808284,"sku":"NG-LIP-VITK2","price":0.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1040\/9223\/8172\/files\/nexagens-placeholder_38d43fa2-8a01-43f2-aee2-3da6091ff964.png?v=1785519798","url":"https:\/\/nexagens.com\/products\/liposomal-vitamin-k2-mk-7-b2b-ingredient","provider":"Nexagens","version":"1.0","type":"link"}